UCLA Fielding School of Public Health

UCLA researchers investigate COVID-19-associated deaths in working-age Latinos

Professors David Hayes-Bautista and Paul Hsu, both with the UCLA Fielding School of Public Health, have found that over the past three months, there was a nearly five-fold increase in death rates among working-age Latinos in California

EMBARGO LIFTS AUGUST 27, 2020, AT 6:00 A.M. PDT

UCLA researchers have found that over the three months from May 11 to August 11, 2020, there was a nearly five-fold increase in death rates in all three groups defined as Latinos of "working age": young adult, early middle age, and late middle age.

"In the early days of the pandemic, we worried about the skyrocketing death rate for the elderly," said David E. Hayes-Bautista, UCLA Fielding School of Public Health (FSPH) professor of health policy and management and distinguished professor of Medicine at the David Geffen School of Medicine at UCLA. "Now the virus is falling on the working-age population, and the young Latino population is disproportionately represented in this demographic."

Hayes-Bautista and Paul Hsu, assistant professor of epidemiology at FSPH and co-author of the report, "COVID-19‒ Associated Deaths in Working-Age Latino Adults," found the following:

  • Latino Young Adult (ages 18‒34). Young adult Latinos include college students and recent graduates beginning their lifetime labor force participation. While the absolute number of deaths in this group—and hence also their death rate—was very low, its rate of growth is nonetheless alarming. In the three months from May 11 to August 11, the death rate for this group increased by 473%.  
  • Latino Early Middle Age (ages 35‒49). Early middle-aged Latinos are consolidating their place in the labor force and are in the process of forming families and households. During the three months between May and August, the death rate in this age group grew just as alarmingly, by 386%.
  • Latino Late Middle Age (ages 50‒69). Late middle-aged Latinos, like most late middle-aged persons, are in their peak earning years. Death rates were far higher for this age group to start with, and during the same three-month period they grew by 471%.

The death rate is highest for late middle-aged Latinos. At 54.73 deaths per 100,000, it is nearly 25 times higher than the young adult rate (2.12), and nearly four times higher than the early middle-aged rate (14.23). COVID-19 is taking a high toll on Latino adults in their peak earning years. The report is published by the Center for the Study of Latino Health and Culture (CESLAC), part of UCLA Health.

“Anything that threatens the stability of our economy, like COVID-19’s inroads into the working-age population, needs to be taken seriously,” Hayes-Bautista said.

Data on COVID-19 deaths, stratified by race/ethnicity and by age group, were furnished by the California Department of Public Health (CDPH) between May 11 and August 11, 2020. Population denominators to calculate the age-specific death rate per 100,000 were tabulated from the 2018 American Community Survey (ACS), the latest available.



Filters close

Showing results

110 of 6112
Newswise: New Study Details Enzyme That Allows Coronavirus to Resist Antiviral Medications
Released: 3-Aug-2021 12:20 PM EDT
New Study Details Enzyme That Allows Coronavirus to Resist Antiviral Medications
Iowa State University

A new Iowa State University study details the structure of a critical enzyme present in SARS-CoV-2, the coronavirus that causes COVID-19. This enzyme removes nucleoside antiviral medications from the virus’s RNA, rendering many treatments ineffective. Scientists could use data uncovered in the new study to find ways to inhibit the enzyme, possibly leading to more effective treatments.

Released: 2-Aug-2021 6:05 PM EDT
Rethinking Remdesivir
University of California San Diego Health

UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.

Newswise: Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Released: 2-Aug-2021 4:25 PM EDT
Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Hackensack Meridian Health

New COVID-19 40-day mortality risk model, published in The Public Library of Science ONE, has potential for use in patient treatment planning, comparisons of therapeutic strategies, and public-health preparations.

Released: 2-Aug-2021 4:05 PM EDT
Town Hall on Effectiveness of COVID-19 Vaccination in Immunosuppressed Patients Hosted by the American College of Rheumatology
American College of Rheumatology (ACR)

How effective COVID-19 vaccines have been in immunosuppressed and rheumatic disease patients remains an incompletely answered question. The American College of Rheumatology (ACR) has organized an expert panel to share what we are learning from real-world data and answer questions.

Released: 2-Aug-2021 2:00 PM EDT
CDC withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test does not mean the test failed
Newswise

Social media is now rife with claims about why the CDC is withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test after December 2021.

Newswise: Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Released: 2-Aug-2021 1:30 PM EDT
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Argonne National Laboratory

Scientists using the Advanced Photon Source have discovered that a drug used to fight tumors in animals might be effective against many types of coronaviruses, including SARS-CoV-2.

Released: 2-Aug-2021 11:25 AM EDT
Award-Winning Journalist and CDC Principal Investigator to Serve as ACR Convergence 2021 Keynote Speaker
American College of Rheumatology (ACR)

Convergence 2021, the annual meeting of the American College of Rheumatology (ACR), returns to a virtual meeting platform Nov. 1 - 10. This year’s meeting will include presentations from over 320 clinicians, researchers and health experts, including this year’s keynote speaker, Dr. Seema Yasmin.

Newswise: COVID-19: Small Sign of Hope as Vaccinations Rise
Released: 2-Aug-2021 10:45 AM EDT
COVID-19: Small Sign of Hope as Vaccinations Rise
Cedars-Sinai

As COVID-19 cases spike in Los Angeles and throughout the Golden State, driven by the spread of the delta variant among unvaccinated residents, there may be a small sign of hope: More people are finally getting their shot.

Newswise: New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
Released: 31-Jul-2021 10:05 AM EDT
New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
University of Miami Health System, Miller School of Medicine

The University’s coronavirus sequencing effort uncovered that there are several variants present in its patient population, but Delta is chief among them and easily transmitted. And its presence is likely triggering a local surge in the infectious disease. University of Miami researchers and physicians are seeing firsthand how rapidly the Delta variant of COVID-19 is spreading through the local population.


Showing results

110 of 6112

close
1.91794